These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 796794)

  • 1. Tolerance and leukaemogenesis.
    Barnes RD
    Pathol Biol (Paris); 1976 Dec; 24(10):713-24. PubMed ID: 796794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to detect anti-group-specific murine leukemia virus activity in tetraparental AKR-CBA chimeras.
    Barnes RD; Tuffrey MA; Bourne RC
    Cancer Res; 1975 Oct; 35(10):2699-703. PubMed ID: 168964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to detect antibody against Gross virus in tetraparental AKR reversible CBA mouse chimaeras.
    Barnes RD; Tuffrey M; Holliday J
    Br J Cancer; 1975 Jan; 31(1):1-6. PubMed ID: 168912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
    Barnes RD; Tuffrey M; Holliday J; Hilgers JH; Souissi T
    Br J Cancer; 1976 Jul; 34(1):28-38. PubMed ID: 182191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of early embryo aggregation derived chimaeras. I. To study immunological tolerance.
    Barnes RD
    J Immunogenet; 1976 Oct; 3(5):347-56. PubMed ID: 13127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour resistance of tetraparental AKR-CBA chimaeras.
    Barnes RD
    Adv Exp Med Biol; 1976; 66():423-9. PubMed ID: 1083648
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes localized in the renal glomeruli of AKR mice: the presence of MuLV gs-I and C-type RNA tumor virus gs-3 determinants.
    Markham RV; Sutherland JC; Cimino EF; Drake WP; Mardiney MR
    Rev Eur Etud Clin Biol; 1972; 17(7):690-4. PubMed ID: 4119502
    [No Abstract]   [Full Text] [Related]  

  • 16. Levels of C-type viral p30 antigens in lymphoma-resistant mice.
    Barnes RD; Tuffrey MA; Crewe P; Dawson L; Brown K; Joyner J
    Cancer Res; 1976 Oct; 36(10):3622-4. PubMed ID: 182358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas.
    Shevach E; Herberman R; Lieberman R; Frank MM; Green I
    J Immunol; 1972 Feb; 108(2):325-8. PubMed ID: 4340285
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in Gross (G) antigen sites on the surface of AKR virus-induced rat lymphoma cells after treatment with trypsin.
    Brandchaft PB; Boone CW
    J Immunol; 1974 Jul; 113(1):94-102. PubMed ID: 4364955
    [No Abstract]   [Full Text] [Related]  

  • 19. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods].
    Lezhneva OM
    Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.